Abstract: Background: QuEChERS (Quick, Easy, Cheap, Effective, Rugged and Safe) is a methodology previously developed to extract pesticides from vegetables and fruits and has been fully applied for different analytical approaches.
INTRODUCTION
Clinical and Forensic Toxicology are strongly based in Analytical Chemistry. Whole blood, urine and solid tissues as well as alternative samples such as oral fluid, hair and meconium are commonly used for toxicological analysis *Address correspondence to these authors at the Department of Biological Sciences, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Rua José Viterbo Ferreira nº 228, 4050-313 Porto, Portugal; Tel: +351 220428597; E-mails: manuhpa@hotmail.com; ricardinis@med.up.pt †The first two authors contributed equally to this work. [1] [2] . The use of such biological matrices demands an extraction/purification pre-treatment before its chromatographic analysis. Solid-phase extraction (SPE) and liquidliquid extraction (LLE) are common techniques used for this purpose. LLE is a classical and simple technique that uses solvents to selectively extract target compounds [3, 4] . However, LLE has a number of drawbacks that limit its use, namely reduced selectivity, large solvent consumption and difficulty of automation. Moreover, formation of emulsions can interfere with the phase-separation process due to the difficulty to separate emulsified organic phases, and errors can occur when extracting compounds of interest, consequently questioning the obtained quantitative values [5] . SPE has high selectivity and has been used for many biological matrices [6] [7] . Although some automation exists, SPE is a complex, laborious, high cost and time-consuming methodology in an extensive multi-steps process [8] .
In 2003, Anastassiades et al. [9] developed a new extraction method named QuEChERS (Quick, Easy, Cheap, Effective, Rugged and Safe) to analyze pesticides in vegetables and fruits, removing sugars, lipids, organic acids, steroids, proteins, pigments and water excess, all in one step. Its advantages are the quicker and easier handling, the use of low solvent volumes and low cost when compared with other extraction methods. This process involves a sample extraction using acetonitrile, followed by addition of anhydrous magnesium sulfate (MgSO 4 ) and sodium chloride (NaCl) to decrease solubility of organic drugs in aqueous phase, and to reduce the amount of water in the organic phase [9] [10] . Only few studies have applied QuEChERS in human samples. Some successful reports, included the extraction of pesticides [11] and drugs of abuse in human whole blood [10, 12] and muscle samples [13] [14] [15] . Most studies applying QuECh-ERS to complex biological samples such as whole blood, describes the use of a pre-treatment step with Primary Secondary Amine (PSA) [8, 12] . PSA showed to be an effective sorbent for removal of various matrices and significantly reducing matrix-enhancement effect. The surface of PSA contains many primary secondary amino groups, which could selectively adsorb fatty acids an important interference in whole blood samples [16] .
Due the large number of cases that every year reaches clinical and forensic laboratories, it is imperative to use fast extraction, detection and quantitative analytical methods to analyze toxicological substances in biological specimens. Opioids have a great role in fatal intoxications in Europe, as reported in The European Report about Drugs. About 3.5% of all deaths of Europeans 15-39 years old were drug overdoses, opioids were found in about three-quarters of fatal overdoses [17] .
Therefore, the goal of our work was the development and validation of a modified QuEChERS method for the simultaneous extraction of 13 opioids from whole blood samples and to analyze them by GC-MS.
MATERIAL AND METHODS

Reagents and Standards
Ethyl acetate and sodium sulfate were purchased from Carlo Erba (Milan, Italy), N-methyl-N-(trimethylsily) trifluoroacetamide (MSTFA) was purchased from SigmaAldrich (St Louis, MO, USA). Magnesium sulfate and sodium chloride in powder form and analytical grade were purchased from Merck (Darmstadt, Germany). Codeine, morphine, heroin, 6-AM, desomorphine, ethylmorphine, methadone, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP), 2-ethyl-5-methyl-3,3-diphenyl-1-pyrroline (EMDP), papaverine, tramadol, tapentadol, cocaine and cocaethylene certified standards were purchased from Lipomed AG (Arlesheim, Switzerland). O-desmetyltramadol (M1) was a generous gift from Grünenthal (Amadora, Portugal). Phenacetin (internal standard, IS) was obtained from LGC Standards. The purity of all standards were higher than 98.5%. Helium C-60 (99.99%) was ordered from Gasin (Portugal). Nitrogen was supplied by AirLiquid (Algés, Portugal). All the reagents used were from the highest available grade.
Sample Collection
Blank whole blood samples for method validation were obtained from healthy volunteers who gave informed consent, and collected in tubes containing EDTA. Any preservative such as sodium fluoride was added.
Preparation of Stock, Quality Control and Working Solutions
Separate commercially available 1 mg/mL methanolic solutions for each analyte and IS were used as stock solutions. They were prepared and stored at -20ºC until use. The heroin solutions were prepared in chloroform due to their instability when stored in methanolic solutions [9] . Working solutions (2000 ng/mL) were prepared by dilution from each stock solution in 1 mL of mL of blank whole blood. For calibration standards and quality control (QC) samples, the working solutions were diluted in blank blood by serial dilutions. For the calibration standards serial dilutions were made to originate the 2000, 1000, 500, 250, 125, 62.5 and 31.2 ng/mL concentrations. For QC spiking solutions (low, 31.2; medium, 250; high, 2000 ng/mL), serial dilutions from the work solutions were also used. No dilution integrity was performed as part of the method validation since selected standard concentrations cover most concentration found in clinical and forensic settings as previously demonstrated [10] .
Samples Extraction Using QuEChERS
For extraction, 300 L of spiked whole blood with work concentrations of each analyte was alkalinized using one drop of NaOH 0.1M, to obtain a pH around 10.0. Samples were vortexed and then centrifuged at 10,000g for 5 minutes. The resulting supernatants were separated and, then sonicated for 5 min in an ultrasonic bath (Fig. 1A) . 300 L of the supernatant was pipetted into a tube containing a previously pulverized mixture of 50mg of NaCl and 100mg of MgSO 4 (1:2), 500 μL of ethyl acetate and two metal spheres. The samples were vortexed for 10 seconds and then centrifuged at 7,300g for 2 minutes. The organic phase was carefully transferred to a dry and clean glass tube. This extraction process was repeated to maximize extraction efficiency. All samples were evaporated to dryness using a nitrogen flow at room temperature (Fig. 1B) . The time effort was approximately 30 minutes for fourteen different samples and a daily calibration curve. 30 L of N-methyl-N-(trimethylsily) trifluoroacetamide (MSTFA) were added and samples heated at 80ºC for 30 min to accomplish silylation. An aliquot of 1 L of the derivatized extract was injected into the GC-IT/MS system (Fig. 1C) .
GC-MS Conditions
Quantitative and qualitative GC-MS analyses were performed on a Trace GC 2000 Series ThermoQuest gas chromatograph equipped with ion-trap GCQ Plus ThermoQuest Finnigan mass detector (Austin, Texas, USA). Chroma-tographic separation was achieved using a capillary columm (30 m 0.25 mm 0.25 m, cross-linked 5% diphenyl and 95% dimethyl polysiloxane) from Restek ® (Pennsylvania, USA) and high-purity helium C-60 as carrier gas. An initial temperature of 80ºC was maintained for 1 min, increased to 300ºC at 10ºC/min rate, and held for 5 min giving a total run time of 28 min. The flow of the carrier gas was maintained at 1.0 mL/min. The injector port was set at 280ºC. Quantification was performed in selected ion monitoring mode (SIM) with splitless injection. The most abundant ions with higher m/z were selected for quantification and, second and third more abundant m/z ions were used for qualification, considering the mass spectra of the standards previously analyzed and the retention times of each analyte [11] [12] [13] . Elucidation of their structures was not performed. The designated m/z for the each analyte is present in Table 1 . For qualitative analysis all analytes were analyzed simultaneously.
Phenacetin was chosen as IS since it proved to be effective for opioids analysis as described previously [14] . Although phenacetin has been reported to be used to "cut" heroin and cocaine samples, we performed a thorough retrospective analysis of forensic intoxication involving heroin and cocaine in Portugal between 2001 and 2013; these cases did not register positivity for phenacetin. Typical recommendations on sample preparation of biological specimens for systematic toxicological analysis suggests that for any systematic toxicological assay procedure, active drugs should only be used as internal standards when no alternative is available and after proofing their absence in the sample, which corresponds to the present case [15] .
Method Validation
The validation of the method was performed accordingly to European Medicines Agency [16] . The evaluated parameters were selectivity, limit of detection (LOD), lower limit of quantification (LLOQ), precision, accuracy, recovery, matrix effect and linearity of the method. Calibration curves were prepared by serial dilutions starting from the working solutions in blank whole blood prepared with standard solutions of codeine, morphine, heroin, 6-AM, desomorphine, ethylmorphine, methadone, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP), 2-ethyl-5-methyl-3,3-diphenyl-1-pyrroline (EMDP), papaverine, tramadol, O-desmetyltramadol (M1), tapentadol, cocaine and cocaethylene. The QC samples were also prepared from working solutions starting from the high concentration with serial dilutions for medium and low concentrations.
Proof of Applicability
Whole blood samples were collected from volunteers undergoing methadone administration as a replacement therapy of heroin dependence and from rats exposed to desomor- phine, tramadol and tapentadol. The human samples were obtained under the consent of the volunteers.
The animal study was performed using adult male Wistar rats obtained from Harlan (Udine, Italy), with mean weight of 250±10g. Animals were kept under standard laboratory conditions (12h/12h light/darkness, 22±2ºC room temperature, 50-60% humidity) for at least 1 week (quarantine) before starting the experiments. Animals were allowed access to tap water and rat chow ad libitum during the quarantine period. Animals' experiments were licensed by the Portuguese General Directorate of Veterinary Medicine and approved by the Ethical Committee of Faculty of Pharmacy of the University of Porto (protocol number 0269/26/EA). Housing and experimental treatment of animals were in accordance with the guidelines defined by the European Council Directive (2010/63/EN). Six male Wistar rats were daily exposed to desomorphine (1 mg/Kg) during five consecutive days. After the last day, animals were euthanized and whole blood was collected. For tapentadol and tramadol analysis sixteen male Wistar rats were divided in two groups. At the first group, tramadol was administered in two doses (therapeutic -10 or toxic -25 mg/Kg) in four animals per dose. The second group had the same procedure but tapentadol was used. Both group animals were euthanized 24 h after the injections to collect whole blood. For both substances experiments, blood was obtained by exsanguination using a hypodermic heparinized needle. Blood samples were centrifuged (3000g, 4ºC, 10 min) and plasma was aliquoted and stored (-80ºC) for further analysis.
RESULTS AND DISCUSSION
Several authors have applied QuEChERS to clean up biological samples for subsequent detection of drugs [8, [17] [18] [19] [20] [21] . Occasionally, sorbents were used after QuEChERS to improve removal of proteins and lipids, which are the most common interferents in biological samples [17] [18] [19] . To develop a fast and reliable method for clinical and forensic applications, we aimed to reduce sample preparation steps in order to minimize errors and cost.
Modified QuEChERS method
Sample clean-up: Sample clean-up is a very important step in toxicological analysis aiming to isolate target substances from tissue interfering components such as proteins and lipids, and to concentrate analytes present in the specimen. This method adds a rapid pre-treatment step using centrifugation and sonication to release the compounds linked to blood proteins, especially albumin, followed by ethyl acetate as the extraction solvent replacing the acetonitrile of the classic QuEChERS methodology. These adaptations were shown to be suitable for the detection and quantification of the tested drugs of abuse in whole blood samples ( Fig. 2A) .
Choice of solvent:
The drug analytes tested are more soluble in ethyl acetate, it is easier and safer to handle, and is considered a "solvent of choice" among a wide variety of multiresidue tests available for different kinds of analytes [22] . Previously, basified acetonitrile was tested as extraction solvent but recoveries lower than 15% were obtained. Raising the ethyl acetate extraction pH to 10 takes into account the chemical nature of all compounds which in an acidic environment should be ionized and consequently not soluble in organic solvents. In our work, the use of an alkaline pH during the extraction process was an important modification to compensate the absence of the Primary Secondary Amine (PSA) step.
Salting out steps:
The "salting out" process follows the original method using MgSO 4 and NaCl salts, being only miniaturized for adaptation to whole blood samples [23] . Anhydrous MgSO 4 is an effective drying agent with an exothermic process of hydration, which increases the extraction efficiency [22, 24] and NaCl decreases the solubility of organic drugs in their aqueous phase, increasing their concentration in the organic solvent.
Sample preservation: Fluoride preservation with a final concentration of 1-5% sodium (or potassium) fluoride by weight is usually recommended for whole blood samples and has great role avoiding the enzymatic loss of esters [1] . The whole blood sample collection was performed using only EDTA once the samples were not stored and all the analysis were performed on the same day after the collection.
Additional drugs: Besides opioids, in this method validation we also included cocaine and cocaethylene. The presence of these compounds relies on the fact that many polydrug users self-administer combinations of heroin with cocaine (i.e., "speedball") and ethanol [25] . Benzoylecgonine is the major cocaine metabolite in plasma by all routes of administration [26] [27] [28] . Although benzoylecgonine is considered pharmacologically inactive, it has a longer elimination plasma half-life (0.5-1.5h versus 4-7h) [32] [33] [34] [35] and, therefore, it is the most commonly monitored metabolite for the determination of cocaine abuse. Although previously considered for validation purposes, benzoilecgonine co-eluted with other analytes and presented low recoveries even after extraction and pH optimization and therefore our QuEChERS methodology proved not be effective for this analyte.
Method Validation
The analytical figures of merit of the developed method are discussed in the following topics.
Selectivity. Selectivity is "the ability of an analytical method to differentiate and quantify the analyte in the presence of other endogenous components in the sample" [16] . Six blank matrix samples were analyzed to evaluate chromatographic interferences. No interference peaks were detected, either in the retention times of all the analytes or in the phenacetin (IS) retention time ( Fig. 2A; Fig. 2B) . Therefore, the analytical method is capable to differentiate our 15 analytes and IS from endogenous components present in the sample.
Carry-over. During the validation process, injections of calibration standards containing 20 g/mL of each analyte (10 times the concentration of the higher curve calibration point) were followed by six blank sample injections of ethyl acetate, to ensure that there was no carry-over from one injection to the next one. The obtained carry-over results were less than 20% of the LLOQ and less than 5% for the IS, which are within the proposed acceptance limits for this parameter [16] .
Matrix Effect. For the matrix effect evaluation six calibration curves were performed. Three curves were prepared using neat standard solutions diluted in pure solvent in a range of 31.2-2000 ng/mL and, three curves were prepared using spiked blank whole blood samples on the same concentration range. The matrix effect factor was calculated considering the response of the analytes with matrix and in the absence of matrix. The values for all analytes were between 80-120%. For the method tested the %CV obtained were less than 15%. Matrix-induced signal enhancement occurs in GC when active surfaces in the system (i.e., injector, column and detector) cause retention and/or degradation of analytes. In standard solutions without sample matrix, only the analytes fill the active sites, which reduce the percentage of injected molecules eventually detected. In complex injected extracts, the active sites are filled predominantly by matrix components, thereby increasing efficiency of analyte transfer through the GC system to the detector [29] . The ionic suppression or enhancement at the interface affects accuracy because standards in pure solvent do not undergo this process [30] . The exact mechanism of ion suppression is not known; it seems that it may be caused by non-volatile material 31 or by compounds of high surface activity [32] . The chemical nature of the analyte plays an important role too. Taylor [33] observed that matrix effects of polar compounds are more relevant than those of less polar compounds. Some instrumental parameters such as the ionization source [31] , ionization mode [34] , and flow rate [35] have been found to influence the extent of the matrix effect. There are different approaches to avoid matrix effect in GC analysis such as adding masking agents or analyte protectants to standards and samples but an efficient clean-up process is the best strategy especially for complex matrices [36] .
Linearity. Peak-area ratios of analytes of interest to the internal standard were calculated. Calibration curves were obtained by plotting peak-area ratios against concentration. The determination coefficient (r 2 ) was obtained for each linear regression of three different curves of each analyte obtained from independent working solutions. The results obtained are showed in Table 2 . The r 2 were >0.98 over the concentration range, showing good linearity for all analytes.
Limit of Detection and Limit of Quantification. LOD and LLOQ were determined based on signal-to-noise ratio, by comparing measured noise signals from samples with known standard concentrations and establishing the minimum concentration level at which analyte can be detected and quantified. A signal-to-noise ratio of 3:1 and 10:1 was considered acceptable for LOD and LLOQ, respectively. The values of LOD and LLOQ are listed on Table 2 . Although LLOQ values obtained were higher than most forensic data in literature, we found them acceptable considering chromatographic system limitations, the time consuming analysis and the cost. Most literature, presents LLOQ data obtained by High Pressure Liquid Chromatography (HPLC) coupled with tandem mass spectrometry (MS) techniques [36] [37] [38] [39] which is much more sensitive for drug analysis. Nevertheless, GC-MS is a useful technique for forensic and clinical analysis due its reproducibility. Lerch and coworkers [40] described a GC-MS technique for detection of opioids and cocaine obtaining slightly lower LLOQ using SPE as the extraction methodology. Even with limitations, our technique showed to be comparable with data described in literature. Moreover, the obtained LLOQ and LOD were derived from a multiresidual operation for simultaneous analysis of thirteen analytes. Improvement of LOD and LLOQ can be made case by case, by reducing the numbers of ions included in the SIM data collection process when a substance is suspected. Indeed, as previously suggested the suspicion is an extremely important pre-analytical step to vectorize which xenobiotics must be included in the toxicological analysis [41] [42] [43] [44] .
Precision, Accuracy and Recovery. The results obtained are showed in Table 2 . Precision was evaluated considering the threshold of 15% for %CV and 20% for the concentration closer to the LLOQ. The precision of the analytical method describes the closeness of repeated individual measures of the analyte. Intra-day precision data was quantified by analyzing peak-area ratios of analytes of interest to the internal standard of three replicates of three different concentrations (low, 31.2; medium, 250; high, 2000 ng/mL) and calculating %CV. Peak-areas ratios of the same three concentrations, injected on three consecutive days, were used to calculate inter-day precision. For this analysis all the samples were freshly fortified and extracted each day of analysis.
The accuracy of an analytical method describes the closeness of the determined value obtained by the method to the nominal concentration of the analyte in percentage [16] . Accuracy percentage should be within ±20% of actual value for LLOQ and ±15% for other concentrations along the linearity range. The accuracy was evaluated by spiking blank whole blood samples with three different analytes concentrations (low, 31.2; medium, 250; high, 2000 ng/mL) and through the calculation of the deviation of the percentage between the calculated and the nominal value obtained from de QC samples concentrations (low, 31.2; medium, 250; high, 2000 ng/mL) [accuracy (%) = (experimental concentration/ QC concentration) 100].
The extraction recovery was calculated comparing the concentration of the analyte extracted from the matrix and the concentration of the analyte in a curve not extracted. It was evaluated by spiking blank whole blood samples with three different analytes concentrations (low, 31.2; medium, 250; high, 2000 ng/mL) and through the calculation of the deviation of the percentage between the extracted and the non-extracted value [Recovery (%) = (extracted [standard]/non-extracted [standard]) 100]. Usually recovery of extraction methods should be between 80-120%. According to Anzillotti and colleagues [8] , for QuEChERS it is acceptable to achieve an overall recovery value of 60-70% for non-, medium-and polar compounds. Therefore, the method showed good recovery values considering there was no dispersive solid-phase extraction (dSPE) step. Moreover, basic pH of extraction step proved to be important to extract basic drugs and may be used as an exchange to the addition of sorbents like primary secondary amine (PSA). We also compared our validated modified QuEChERS methodology with classic solid-phase extraction (SPE). Considering the basic nature of analytes, Oasis MCX SPE Column was used. Although slightly higher recoveries were obtained with SPE (data not shown), the cost and the time consuming were significantly greater. Moreover, QuEChERS methodology proved to be effective in the proof of applicability step.
Stability. Stability studies were performed concurrently with precision and accuracy analysis. The stock solutions of the analytes did not show deviations (i.e., acceptable %CV) during the 85 days that took the optimization and validation process.
PROOF OF APPLICABILITY
From all 34 human samples, 23 were positive for opioids (Table S1) , namely methadone and its main metabolites, EDDP and EMDP. Methadone therapy is the most extensively evaluated and most used treatment for opioids addiction [45] . It occurs due to its pharmacological characteristics such as high oral bioavailability, long half-live and the availability of a specific antagonist, needed for overdose cases [46] . In Portugal, the therapy consist in a weekly dose of 40 mg of methadone chloride, which may be progressively increased until 200 mg, lasting 1 to 3 years. The variability of methadone concentrations observed in our samples may be due to its kinetic characteristics and the inter-individual variability of absorption and metabolism. Methadone taken orally suffers first-pass effect and is detectable in plasma about 30 min after its administration [46] , occurring the plasmatic peak after 4 hours [47] . Its oral bioavailability varies from 41-95% [47] . Consequently, following the administration of equal doses, quite different whole blood concentrations are obtained in different subjects [46, 47] . Two samples presented low concentrations of tramadol and M1 and, one sample showed M1 under the LLOQ (data not showed). This may be explained by the fact that even in the most effective rehabilitation programs a non-negligible number of the patients still continue using opioids [45] .
In both in vivo experiments, our developed method proved to be effective to detect and quantify therapeutic and toxic concentrations of tapentadol (Table S2) , tramadol and O-desmethyltramadol (Table S3) .
CONCLUSIONS
A sensitive, reproducible and relatively simple GC-MS method was developed and validated for qualitative and quantitative analysis of 15 drugs in whole blood samples. Since this method requires no special equipment, it is less laborious and consumes a minimal time, it shows a great potential as a useful tool for clinical and forensic routine analysis. Moreover, since original QuEChERS methodology is not adapted for highly complex matrix such as whole blood, dSPE with the addition of PSA are usually required. Our modified QuEChERS methodology was validated even without these steps. Whole blood was considered in this work since it is a frequent sample namely in postmortem toxicology [1, 2] . Other samples, such as serum, liver, kidney and lung, muscle and adipose tissue should be considered for further work to widen the applicability of the developed method in clinical and forensic toxicology [48, 49] .
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